US EditionPublished • loading... • Updated
IDEXX Laboratories Touts “Exceptional” Q4, Targets 8%-10% 2026 Growth at BofA Summit
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
IDEXX Laboratories Touts “Exceptional” Q4, Targets 8%-10% 2026 Growth at BofA Summit
IDEXX Laboratories (NASDAQ:IDXX) executives highlighted what they described as “exceptional” fourth-quarter results and outlined key priorities for 2026 during Bank of America’s 2026 Animal Health Summit. The discussion featured Executive Vice President and CFO Andrew Emerson and Executive Vice President Mike Lane, who leads global reference laboratories, diagnostic solutions, and information technology. Fourth-quarter performance and […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
